10/8/2020 | Influenza Vaccine for the 2020-2021 Season |
10/7/2020 | Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting Presentation- Speaker |
10/7/2020 | October 1, 2020 Untitled Letter - Optimal Health Stem Cell and Wellness Institute dba OHSTEMCELL |
10/7/2020 | Summary of Safety and Effectiveness -DPP HIV-Syphilis System |
10/7/2020 | Influenza Vaccine for the 2020-2021 Season |
10/7/2020 | BK200498 - NexSys PCS Plasma Collection System with Persona Technology |
10/6/2020 | Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry |
10/6/2020 | eSubmitter Application History |
10/6/2020 | FDA Briefing Document for Vaccines and Related Biological Products Advisory Committee October 22, 2020 Meeting |
10/5/2020 | September 24, 2020 Approval Letter - HAEGARDA |
10/5/2020 | Regenerative Medicine Advanced Therapy Designation |
10/2/2020 | Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Deviation Codes |
10/2/2020 | Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Non-Blood Product Codes |
10/2/2020 | Biological Product Deviation Reporting -- Blood Product Codes |
10/2/2020 | October 1, 2020 Approval Order - DPP HIV-Syphilis System |
10/2/2020 | Complete List of Licensed Products and Establishments |
10/2/2020 | Complete List of Substantially Equivalent 510(k) Device Applications |
10/2/2020 | Complete List of Currently Approved Premarket Approvals (PMAs) |
10/2/2020 | Complete List of Currently Approved NDA and ANDA Application Submissions |
10/1/2020 | BK200488 - ASI Automated RPR test for Syphilis for use on the ASI Evolution |
10/1/2020 | Influenza Vaccine for the 2020-2021 Season |
9/30/2020 | Considerations for the Use of Real-World Evidence to Assess the Effectiveness of Preventive Vaccines Recordings |
9/30/2020 | September 25, 2020 Approval Letter - IXINITY |
9/29/2020 | September 28, 2020 Approval Letter - ALBAcyte |
9/28/2020 | September 25, 2020 Approval Letter - VAXELIS |
9/25/2020 | September 25, 2020 Approval Letter - PNEUMOVAX 23 |
9/24/2020 | Influenza Vaccine for the 2020-2021 Season |
9/23/2020 | 2020 Biological License Application Supplement Noteworthy Approvals |
9/23/2020 | 2020 Biological Device Application Approvals |
9/21/2020 | Countering Bioterrorism and Emerging Infectious Diseases |
9/17/2020 | Influenza Vaccine for the 2020-2021 Season |
9/17/2020 | September 15, 2020 Approval Letter - ProQuad |
9/16/2020 | September 15, 2020 Approval Letter - VARIVAX |
9/10/2020 | Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2020 |
9/10/2020 | September 9, 2020 Approval Letter - ODACTRA |
9/10/2020 | Influenza Vaccine for the 2020-2021 Season |
9/8/2020 | September 3, 2020 Untitled Letter - Laguna Beach Aesthetics, Cosmetic Dermatology and Laser Center, PC |
9/8/2020 | eSubmitter Application History |
No hay comentarios:
Publicar un comentario